There are an increasing number of radiation therapy patients with hip prosthesis.
of the bone, and potential failure of the prosthetic device. Avoiding these complications may become a controlling factor in planning treatments near high-z materials.
The effect of high-z materials in external beam radiation therapy has been studied extensively. Das 3 studied the backscatter dose at the interface of materials ranging from bone to lead. By comparing the dose at a reference depth in a homogeneous polystyrene block and that at the same depth with the introduction of a slab of high-z material, backscatter dose factors (BSDFs) were calculated. The BSDF, as determined by Das, for common prosthetic device materials such as stainless steel, titanium, or cobalt-chromium-molybdenum, fall somewhere between 1.2 and 1.35. Erlanson 4 studied the dose enhancement in the periphery of hip prosthesis and reported a dose enhancement of 25% at the vicinity of prosthesis.
Even though the common practice is to avoid the beams passing through high-z prosthesis, this may not be possible in all situations.
Overcoming the shadow effects of placing the prosthesis between the radiation source and the intended treatment volume may be problematic. Williams 5 proposed a method to overcome the shadow effects by using an initial field and adding an additional boost field in the area where the prosthesis was located to deliver the intended dose to the treatment site. In addition, the treatment beams often exit through the prosthesis.
Metallic implants also present a challenge in imaging the treatment volume because they lead to poor quality CT scans. High-z materials absorb and harden the beam which leads to streaking artifacts when the image is reconstructed. Poor quality CT images can lead to degraded diagnosis and identification of treatment planning regions of interest, and incorrect assignment of density for dose calculations. The reduction of treatment planning errors from reconstruction artifacts was studied by Bazalova. Three megavoltage beam energies were used in this study. TLDs. The TLDs were not annealed at a low temperature prior to analysis. Instead, the glow peaks that decay quickly were eliminated TomoTherapy units has been subject of investigations but one recent publication points to its stability post-2011. 13 The TomoTherapy unit used for scanning the phantom is subject to the weekly calibration and monthly evaluation of the CT-to-density curve as recommended by Accuray and AAPM Task Group 148.
| METHODS
14 Treatment plans were created in both systems delivering 400 cGy to the isocenter using 6, 10, and 18 MV photons utilizing four fields. The dose grid resolution was set to 0.1 cm 3 in both planning systems. As the CT number of the prosthesis is outside the standard Hounsfield unit range on CT scans, the prosthesis was assigned a density of 7.9 g/cm Dose calculations were performed using collapse cone convolution (CCC) algorithm in Pinnacle and both analytical anisotropic algorithm (AAA) and Acuros XB (AXB) algorithm in eclipse. The dose distribution from one of the Pinnacle treatment plans is shown in Fig. 3 .
The plans were delivered to the phantom using an Elekta Synergy linear accelerator (Elekta). The TLDs were positioned prior to delivery in the phantom and promptly removed following irradiation.
Each plan was delivered to the phantom three times. As with the determination of calibration factors, the TLDs were read approximately 36 h post irradiation.
The plans were also delivered to phantom with the OSLDs in place to compare measured and calculated doses at points far from interface. In addition, a mixed energy (6, 10, 18 MV) AP/PA plan was also generated and delivered to the phantom with the OSLDs in place. This plan served as a control one as the beams did not traverse the prosthesis. The OSLDs were read after approximately 30 min using a MicroStar InLight reader (Landauer). Due to dose dependence of OSLDs, three sets of calibration curves, a low dose, high dose, and an ultra high one, were created to convert the emitted light to dose.
| RESULTS
The calculated and measured doses and their percentage differences are shown in Tables 1-3 There are several publications evaluating at the interface dose at the prosthesis. For example, Ding 7 employed MC to evaluate the dose at the interface of stainless steel rods (density: 7.9 g/cc) for 18 MV x rays, pointing to a 15% dose increase in tissue at the metal interface, and its underestimation by correction-based algorithm 
| CONCLUSION S
The Pinnacle 3 treatment planning system and its CCC dose calculation algorithm, as well as Eclipse treatment planning system and its AAA and AXB algorithms were evaluated for their ability to predict the dose at the surface of a hip prosthesis within the treatment field.
The results indicate that there is a consistent underprediction of the dose at the interface, irrespective of the energy and algorithm used.
The dose enhancement at the interface could lead to additional complications for patients with high-z hip implants including premature failure of the prosthesis from bone necrosis or demineralization.
With greater understanding of the dose distribution, treatment planners can make more informed decisions regarding high-density prosthetic materials in the treatment field and potentially improve longterm patient outcomes. 
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